Abbott Laboratories ABT recently made its FreeStyle Libre 3 Plus sensor available to Canadians living with diabetes. This latest generation glucose monitoring device features the world's smallest ...

With regard to the capture of hypoglycaemia, the manufacturer of FreeStyle Libre has reported their sensor may have less accuracy in the lower glucose ranges when compared with SMBG.

The FreeStyle Libre 3 (FSL3) is a real-time continuous glucose monitoring (CGM) system designed to replace SMBG. The evidence for the benefit of CGM in people with T2DM on non-intensive insulin ...

The bullish scenario where Abbott gains momentum in weight-loss solutions and sees FreeStyle Libre adoption continue rising could push the stock toward $160+, a 27% gain.

Pickled red onions are delicious served alongside fried fish, barbecue, grilled steaks, on a Classic Southern vegetable plate, or chopped and stirred into slaws and salads. You only need one large, ...

Abbott (NYSE: ABT) today announced that the Government of Alberta has added Abbott's FreeStyle Libre 2* flash glucose monitoring system to the Alberta Drug Benefit List.

The FreeStyle Libre GCM can monitor your glucose levels without needing a blood sample. Here’s what you should know about how to use it, where you can get it, and how it compares to other ...

Abbott recalls some FreeStyle Libre 3 sensors due to incorrect glucose readings, risking severe health issues.

A small number of sensors that read blood sugar levels continuously may give incorrect info. Here's how to check your FreeStyle Libre 3 for a replacement.

All the info a person with diabetes would need to choose between Dexcom and the Abbott Libre continuous glucose monitor.

Data analyses show that people with Type 2 diabetes using GLP-1 medicines saw a significant improvement in their HbA1C after adding FreeStyle Libre technology to their regimen Better HbA1c results ...